Create
Log in
Enquire now
Cellectis
Cellectis is a biopharmaceutical company developing cancer immunotherapies.
Overview
Structured Data
Issues
Contributors
Access by API
Access by API
Is a
Company
Organization
B2X
B2B
CEO
André Choulika
CIK Number
1,627,281
Legal Name
Cellectis S.A.
Company Operating Status
Active
Country
France
Crunchbase URL
crunchbase.com/organiz...ellectis
Date Incorporated
December 1, 1999
Founded Date
1999
0
Founder
André Choulika
Full Address
8 RUE DE LA CROIX JARRY 75013, PARIS, ILE-DE-FRANCEFrance
Headquarters
France
Industry
Immunotherapy
Oncology
Stem cell
Healthcare
Genome editing
Biomedical engineering
Biopharmaceutical
Cancer
Genetics
Genomics
•••
Investors
4BIO Capital
Andera Partners
ODYSSEE VENTURE
IDInvest Partners
Ridgeback Capital
BankInvest Biomedical Venture
Latest Funding Round Date
April 2018
Latest Funding Type
Series C
Legal classification
S.A. (corporation)
LinkedIn URL
@company/cellectis
Location
New York City
Raleigh, North Carolina
North Carolina
France
Paris
Number of Employees (Ranges)
51 – 200
Patents Assigned (Count)
64
Phone Number
+33181691600
Pitchbook URL
pitchbook.com/profiles.../55591-21
Exchange
Nasdaq
Stock Symbol
CLLS
Technologies Used
CRISPR
Ticker Symbol
CLLS
Total Funding Amount (USD)
185,049,023
Twitter URL
@cellectis
Official Website
cellectis.com/about-us
cellectis.com/en
cellectis.com
Wikidata ID
Q2943995
Find more companies like Cellectis
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE